国际眼科纵览 ›› 2024, Vol. 48 ›› Issue (1): 46-50.doi: 10.3760/ cma.j.issn.1673-5803.2024.01.009

• 综述 • 上一篇    下一篇

老视治疗研究进展

姚沁楠  万修华   

  1. 首都医科大学附属北京同仁医院  北京同仁眼科中心  眼科学与视觉科学北京市重点实验室,北京 100730
  • 收稿日期:2023-04-23 出版日期:2024-02-25 发布日期:2024-02-28
  • 通讯作者: 万修华,Email:xiuhuawan@163.com
  • 基金资助:
    国家自然科学基金(82171037);北京市医院管理中心临床医学发展专项经费资助(XLMX202133)

Research status of presbyopia treatment

Yao Qinnan, Wan Xinhua   

  1. Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University; Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing 100730, China

  • Received:2023-04-23 Online:2024-02-25 Published:2024-02-28
  • Contact: Wan Xiuhua, Email: xiuhuawan@163.com
  • Supported by:
    National Natural Science Foundation of China(82171037); Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support (XLMX202133)  

摘要: 目前临床治疗老视的方法众多,包括戴框架眼镜和隐形眼镜矫正,角膜和晶状体手术治疗,缩瞳类及晶状体软化剂类药物治疗,综合调节恢复治疗等,各有优劣,但尚无真正意义改善调节功能的方法。本文就老视的治疗现状以及亟待解决的问题进行阐述和分析,并提供未来潜在治疗方案的概述,为临床工作的开展提供指导。(国际眼科纵览,2024, 48:46-50

关键词: 老视, 接触镜, 眼科手术, 药物疗法

Abstract: Nowadays, there are many clinical strategies to correct presbyopia including wearing frame glasses and contact lens correction, corneal and lens surgery, pupil constriction and lens softener drugs treatment, comprehensive adjustment recovery treatment, etc, each of which has its own advantages and disadvantages, however, there is no real way to restore accommodation. This article reviews the progress of presbyopia correction modalities, surgical approaches and drug therapies. (Int Rev Ophthalmol, 2024, 48:  46-50)

Key words: presbyopia, contact lenses, ophthalmic surgery, pharmacotherapy